Functional regulatory T cells produced by inhibiting cyclic nucleotide phosphodiesterase type 3 prevent allograft rejection.
Regulatory T cells (T(regs)) manipulated ex vivo have potential as cellular therapeutics in autoimmunity and transplantation. Although it is possible to expand naturally occurring T(regs), an attractive alternative possibility, particularly suited to solid organ and bone marrow transplantation, is t...
Auteurs principaux: | Feng, G, Nadig, SN, Bäckdahl, L, Beck, S, Francis, R, Schiopu, A, Whatcott, A, Wood, K, Bushell, A |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
2011
|
Documents similaires
-
Cyclic nucleotide phosphodiesterases in health and disease /
par: Beavo, Joe, et autres
Publié: (2007) -
Ex vivo-expanded human regulatory T cells prevent the rejection of skin allografts in a humanized mouse model.
par: Issa, F, et autres
Publié: (2010) -
A brief in vitro activation is sufficient to equip naturally-occurring regulatory T Cells to control allograft rejection long-term
par: Chan, T, et autres
Publié: (2014) -
Cyclic nucleotide specific phosphodiesterases of <it>Leishmania major</it>
par: Linder Markus, et autres
Publié: (2006-03-01) -
Role of Cyclic Nucleotide Phosphodiesterases in Inner Ear and Hearing
par: Rahul Mittal, et autres
Publié: (2017-11-01)